Evidence map›Paper›PMID 30154095›Full record

ReviewBiochemical Society transactions2018

Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body.

Régis Stentz, Ana L Carvalho, Emily J Jones, Simon R Carding

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. SypC, a symbiont outer membrane vesicle protein, impacts the development of the squid-vibrio partnership.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Review
  13. Frontiers in bacterial outer membrane vesicles: From basic characteristics to cancer therapy.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Secretory phospholipase ACommunications biology · 2025
    Article
  19. Lessons from the model gut BacteroidalesJournal of bacteriology · 2025
    Review
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Régis StentzGut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UA, U.K. regis.stentz@quadram.ac.uk simon.carding@quadram.ac.uk.
Ana L CarvalhoGut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UA, U.K.
Emily J JonesGut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UA, U.K.
Simon R CardingGut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UA, U.K. regis.stentz@quadram.ac.uk simon.carding@quadram.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/J004529/1Biotechnology and Biological Sciences Research Council BB/L004291/1Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10353Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10355
6 · The paper itself

Abstract

As part of their life cycle, Gram-negative bacteria produce and release microvesicles (outer membrane vesicles, OMVs) consisting of spherical protrusions of the outer membrane that encapsulate periplasmic contents. OMVs produced by commensal bacteria in the gastrointestinal (GI) tract of animals are dispersed within the gut lumen with their cargo and enzymes being distributed across and throughout the GI tract. Their ultimate destination and fate is unclear although they can interact with and cross the intestinal epithelium using different entry pathways and access underlying immune cells in the lamina propria. OMVs have also been found in the bloodstream from which they can access various tissues and possibly the brain. The nanosize and non-replicative status of OMVs together with their resistance to enzyme degradation and low pH, alongside their ability to interact with the host, make them ideal candidates for delivering biologics to mucosal sites, such as the GI and the respiratory tract. In this mini-review, we discuss the fate of OMVs produced in the GI tract of animals with a focus on vesicles released by

Indexed as

Gastrointestinal MicrobiomeAnimalsBacterial Outer Membrane ProteinsBacteroidesBrainEpithelial CellsGastrointestinal TractGram-Negative BacteriaHost-Pathogen InteractionsHumansImmune SystemIntestinal MucosaSecretory VesiclesBacterial Outer Membrane ProteinsBacteroidesgut microbiotahost–microbe interactionsouter membrane vesiclesvaccine

Identifiers

PMID30154095
PMCPMC6195637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.